Table 2.
Groups | Experimental group (n=60) | Control group (n=60) | t | P |
---|---|---|---|---|
IL-1β (ng/L) | ||||
Before treatment | 130.68±10.52 | 131.25±10.54 | 0.296 | 0.767 |
After treatment | 28.21±4.23 | 70.68±5.68 | 46.451 | <0.001 |
IL-6 (ng/L) | ||||
Before treatment | 152.14±12.24 | 152.68±12.10 | 0.243 | 0.808 |
After treatment | 35.98±3.58 | 69.12±5.41 | 39.570 | <0.001 |
CRP (mg/dl) | ||||
Before treatment | 10.12±1.05 | 10.15±1.06 | 0.156 | 0.877 |
After treatment | 2.41±0.65 | 5.89±0.41 | 35.076 | <0.001 |